PHAT·71722W107·US·equity·Healthcare - Biotechnology-Activist
PHAT (PHATHOM PHARMACEUTICALS INC) is held by 96 institutional investors as of Q1 2026. Largest holders: Invesco Ltd. ($48M), BlackRock, Inc. ($45.1M), MILLENNIUM MANAGEMENT LLC ($44.7M). Net institutional sentiment: Mixed.
See how PHAT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer